Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Relationship between changes i...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
Bibliographic Details
Main Authors:
Watts, N
,
Cooper, C
,
Lindsay, R
,
Eastell, R
,
Manhart, MD
,
Barton, I
,
van Staa, T
,
Adachi, J
Format:
Journal article
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
by: Watts, N, et al.
Published: (2004)
VERTEBRAL FRACTURE RISK REDUCTION IS INDEPENDENT OF THE MAGNITUDE OF BMD CHANGE
by: Adachi, J, et al.
Published: (2004)
The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
by: van Staa, T, et al.
Published: (2003)
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
by: Van Staa, T, et al.
Published: (2003)
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2012)